Combined immunochemotherapy (R-FCM) is superior to chemo-therapy (FCM) alone in recurrent indolent lymphoma - results of a prospective randomized comparison

European Journal of Cancer(2001)

Cited 0|Views8
No score
Key words
recurrent indolent lymphoma,combined immunochemotherapy,r-fcm,chemo-therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined